Identification of Multi-Target Anti-AD Chemical Constituents From Traditional Chinese Medicine Formulae by Integrating Virtual Screening and In Vitro Validation

虚拟筛选 中医药 疾病 对接(动物) 计算生物学 药品 药物发现 药理学 体外 医学 生物 化学 生物化学 内科学 护理部 病理 替代医学
作者
Baoyue Zhang,Jun Zhao,Zhe Wang,Pengfei Guo,Ailin Liu,Guanhua Du
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:12: 709607-709607 被引量:23
标识
DOI:10.3389/fphar.2021.709607
摘要

Alzheimer's disease (AD) is a neurodegenerative disease that seriously threatens the health of the elderly. At present, no drugs have been proven to cure or delay the progression of the disease. Due to the multifactorial aetiology of this disease, the multi-target-directed ligand (MTDL) approach provides an innovative and promising idea in search for new drugs against AD. In order to find potential multi-target anti-AD drugs from traditional Chinese medicine (TCM) formulae, a compound database derived from anti-AD Chinese herbal formulae was constructed and predicted by the anti-AD multi-target drug prediction platform established in our laboratory. By analyzing the results of virtual screening, 226 chemical constituents with 3 or more potential AD-related targets were collected, from which 16 compounds that were predicted to combat AD through various mechanisms were chosen for biological validation. Several cell models were established to validate the anti-AD effects of these compounds, including KCl, Aβ, okadaic acid (OA), SNP and H2O2 induced SH-SY5Y cell model and LPS induced BV2 microglia model. The experimental results showed that 12 compounds including Nonivamide, Bavachromene and 3,4-Dimethoxycinnamic acid could protect model cells from AD-related damages and showed potential anti-AD activity. Furthermore, the potential targets of Nonivamide were investigated by molecular docking study and analysis with CDOCKER revealed the possible binding mode of Nonivamide with its predicted targets. In summary, 12 potential multi-target anti-AD compounds have been found from anti-AD TCM formulae by comprehensive application of computational prediction, molecular docking method and biological validation, which laid a theoretical and experimental foundation for in-depth study, also providing important information and new research ideas for the discovery of anti-AD compounds from traditional Chinese medicine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
吴家豪发布了新的文献求助10
1秒前
不是搞笑男完成签到,获得积分10
1秒前
1秒前
轻松不二完成签到,获得积分10
1秒前
杨耑耑完成签到 ,获得积分10
1秒前
LSY发布了新的文献求助10
1秒前
2秒前
2秒前
萧a完成签到,获得积分10
2秒前
幸福飞松发布了新的文献求助10
2秒前
2秒前
晕晕晕完成签到,获得积分10
3秒前
orixero的应助被危机的傲易采纳,获得10
3秒前
无私的电灯胆完成签到,获得积分10
3秒前
4秒前
玛卡巴卡发布了新的文献求助10
4秒前
4秒前
达达完成签到 ,获得积分10
5秒前
Ava的应助被000采纳,获得10
5秒前
5秒前
5秒前
阳光时光完成签到,获得积分20
5秒前
鲁杨雪完成签到,获得积分10
5秒前
5秒前
蚂蚁完成签到,获得积分10
5秒前
zhou完成签到,获得积分10
5秒前
大模型的应助被pp采纳,获得10
5秒前
5秒前
木南发布了新的文献求助10
6秒前
Estella完成签到,获得积分10
6秒前
苹果秋完成签到 ,获得积分10
6秒前
大模型的应助被着急的寻真采纳,获得10
7秒前
zhou完成签到,获得积分10
8秒前
搞怪乐珍发布了新的文献求助10
8秒前
8秒前
兰球完成签到,获得积分10
8秒前
巴拉巴拉完成签到,获得积分20
9秒前
吞吞完成签到 ,获得积分10
9秒前
阳光时光发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea De Guyane 2000
Guidelines for fracture-safe and fatigue-reliable design of steel structures 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
Organizational Behavior 510
Atelier, 2nd edition 500
Study of structural arctic steel in a friction pair with ice 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 7994514
求助须知:如何正确求助?哪些是违规求助? 9449444
关于积分的说明 21125235
捐赠科研通 7567964
什么是DOI,文献DOI怎么找? 3379446
关于科研通互助平台的介绍 2513156
邀请新用户注册赠送积分活动 2413270